E-LIB Suche - Ergebnisse für: Bánhegyi, Péter

1

In Silico, In Vitro and In Vivo Pharmacodynamic Characteriz..:

Kántás, Boglárka ; Szőke, Éva ; Börzsei, Rita...
Frontiers in Pharmacology. 11 (2021) - p. , 2021

2

Novel Drug-Like Somatostatin Receptor 4 Agonists are Potent..:

Kántás, Boglárka ; Börzsei, Rita ; Szőke, Éva...
International Journal of Molecular Sciences. 20 (2019) 24 - p. 6245 , 2019

Link: https://doi.org/10.3390/..

3

Targeted drug combination therapy design based on driver ge..:

Zsákai, Lilian ; Sipos, Anna ; Dobos, Judit...
Oncotarget. 10 (2019) 51 - p. 5255-5266 , 2019

Link: https://doi.org/10.18632..

4

Discovery and optimization of novel benzothiophene-3-carbox..:

Gyulavári, Pál ; Szokol, Bálint ; Szabadkai, István...
Bioorganic & Medicinal Chemistry Letters. 28 (2018) 19 - p. 3265-3270 , 2018

Link: https://doi.org/10.1016/..

5

Novel compounds with potent CDK9 inhibitory activity for th..:

Czudor, Zsófia ; Balogh, Mária ; Bánhegyi, Péter...
Bioorganic & Medicinal Chemistry Letters. 28 (2018) 4 - p. 769-773 , 2018

Link: https://doi.org/10.1016/..

6

Characterization of new, efficient Mycobacterium tuberculos..:

Temesszentandrási-Ambrus, Csilla ; Tóth, Szilárd ; Verma, Rinkee...
PLOS ONE. 13 (2018) 9 - p. e0202749 , 2018

Link: https://doi.org/10.1371/..

7

Novel compounds reducing IRS-1 serine phosphorylation for t..:

Simon-Szabó, Laura ; Kokas, Márton ; Greff, Zoltán...
Bioorganic & Medicinal Chemistry Letters. 26 (2016) 2 - p. 424-428 , 2016

Link: https://doi.org/10.1016/..

8

New Method for the Synthesis of 2-Acylamino-1-benzothiophen..:

Bánhegyi, Péter ; Wáczek, Frigyes ; Székelyhidi, Zsolt...
Synthetic Communications. 38 (2008) 19 - p. 3270-3276 , 2008

Link: https://doi.org/10.1080/..

9

Synthesis of selective SRPK-1 inhibitors: Novel tricyclic q..:

Székelyhidi, Zsolt ; Pató, János ; Wáczek, Frigyes...
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 13 - p. 3241-3246 , 2005

Link: https://doi.org/10.1016/..

10

Drug Discovery in the Kinase Inhibitory Field Using the Nes..:

Kéri, György ; Székelyhidi, Zsolt ; Bánhegyi, Péter...
ASSAY and Drug Development Technologies. 3 (2005) 5 - p. 543-551 , 2005

Link: https://doi.org/10.1089/..

11

In Silico, In Vitro and In Vivo Pharmacodynamic Characteriz..:

Kántás, Boglárka ; Szőke, Éva ; Börzsei, Rita...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015869/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Novel Drug-Like Somatostatin Receptor 4 Agonists are Potent..:

Kántás, Boglárka ; Börzsei, Rita ; Szőke, Éva...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940912/. , 2019

Link: http://www.ncbi.nlm.nih...

13

datasheet1_In Silico, In Vitro and In Vivo Pharmacodynamic ..:

Boglárka Kántás ; Éva Szőke ; Rita Börzsei...
doi:10.3389/fphar.2020.601887.s001. , 2021

Link: https://doi.org/10.3389/..

14

datasheet1_In Silico, In Vitro and In Vivo Pharmacodynamic ..:

Boglárka Kántás ; Éva Szőke ; Rita Börzsei...
doi:10.3389/fphar.2020.601887.s001. , 2021

Link: https://doi.org/10.3389/..

15

datasheet1_In Silico, In Vitro and In Vivo Pharmacodynamic ..:

Boglárka Kántás ; Éva Szőke ; Rita Börzsei...
doi:10.3389/fphar.2020.601887.s001. , 2021

Link: https://doi.org/10.3389/..